Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Oct 5, 2021

Later deadlines: Nov 5, 2021, Jan 7, 2022

Grant amount: Unspecified amount

Fields of work: Neurological Diseases & Disorders

Applicant type: Organizations

Funding uses: Non-clinical Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: Applications are due by 5pm submitter's local time on the following dates:

  • Non-AIDS Applications:
    • New applications are due on February 5, June 5, and October 5 annually.
    • Renewal applications are due on March 5, July 5, and November 5 annually.
  • AIDS Applications are due on January 7, May 7, and September 7 annually.

This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIMH and NIA wish to stimulate research in:

  • Identification, design, synthesis, and preclinical testing of compounds of candidate therapeutics;
  • Initial hit-to-lead chemistry to improve activity of compounds against the target of interest;
  • Later stage lead optimization to improve efficacy and pharmacokinetics; and
  • Initial drug metabolism and pharmacokinetic (DMPK).

Emphasis will be placed on projects that provide novel approaches for identifying potential therapeutic agents.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed January 10, 2019 and last updated January 10, 2019